Cite
MLA Citation
Aaron J. Ahearn et al.. “A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients.” Transplantation, vol. 106, no. 2, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100180900193.0x000041